MedTrace Logo

Air-in-Line Alarms During Antineoplastic Drug Infusion

NCT07718711 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2026-07-22

No results posted yet for this study

Summary

The goal of this observational study is to evaluate infusion alarms, particularly air-in-line alarms, during antineoplastic drug infusion in oncology care settings.

The main questions it aims to answer are:

How frequently do infusion alarms occur, and what types of alarms are observed during antineoplastic drug infusion? How long does it take healthcare professionals to manage infusion alarms and restore infusion continuity? What strategies do healthcare professionals use to manage infusion alarms? How do healthcare professionals evaluate the user experience of different infusion technologies?

Participants will be healthcare professionals involved in antineoplastic drug infusion. They will not receive any experimental intervention. Researchers will observe routine infusion procedures and collect data on alarm events, alarm management, infusion technologies, and user experience.

Conditions

  • Infusion Safety
  • Medication Safety
  • Antineoplastic Drug Administration
  • Air-in-Line Alarm

Interventions

OTHER

Routine Infusion Technologies

Observation of routinely used infusion technologies and infusion-related alarm management during standard antineoplastic drug administration in oncology care settings. No experimental intervention or treatment allocation is performed.

Sponsors & Collaborators

  • IRCCS Multimedica

    collaborator OTHER

  • University of Milan

    collaborator OTHER

  • Associazione Italiana Infermieri di Area Oncologica

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-01
Primary Completion
2028-06-01
Completion
2028-06-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07718711 on ClinicalTrials.gov